C O M M U N I C A T I O N S
constrained to the conformation found in a DNA strand, and also
lacks the phosphodiester bridge and oligonucleotide strand that
likely contribute considerably to substrate binding interactions in
the SPL active site. We have incorporated the protected SP
phosphotriester described in the Supporting Information into an
oligo; however, our initial assays on this indicated that the enzyme
cannot repair the di-SEM protected SP analogue. Carell has also
incorporated a synthetic SP analogue into an oligonucleotide strand,
however the analogue contains no phosphodiester linkage; no assay
data on the resulting oligos were presented.16 We are currently
pursuing deprotection of the SP phosphotriesters (SI) and incor-
poration of them into oligonucleotide DNA, to produce stere-
ochemically defined substrates for further assay and mechanistic
studies.
The results presented herein provide direct and quantitative
evidence for the stereochemical requirements of SP repair by SPL,
demonstrating that SPL repairs specifically the 5R isomer of SP.
The identification of 5R-SP as the substrate of SPL supports the
premise that SP, like the more familiar cyclobutane thymine dimer,
is a result of UV-induced dimerization of adjacent thymines in a
DNA strand. Furthermore, the observation that only 5R-SP is a
substrate for SPL is consistent with the expectation, based on the
constraints imposed by the DNA double helical structure, that 5R
is the SP isomer produced in ViVo upon UV irradiation of bacterial
spore DNA, an expectation supported by a recent report showing
that 5R SP is the diastereomer produced upon UV irradiation of a
TpT dinucleotide.17
Figure 2. HPLC chromatograms showing the time-dependent formation
of thymidine due to repair of R-SP (A) but not S-SP (B), upon incubation
of 1 mM SP with SPL (50 µM), AdoMet (1 mM), DTT (5 mM), and
dithionite (1 mM) in buffer (see SI) at 30 °C. SP elutes at 19.3 (5R) or
20.3 (5S) min and thymidine elutes at 14.4 min under these conditions.
Integration of the thymidine and SP peaks allowed the quantitation of
turnover of each isomer of SP (C).
Acknowledgment. The authors thank the National Institutes of
Health for financial support of this research (GM67804). We
gratefully acknowledge the assistance of Valerie Copie on NMR
experiments and Robert Szilagyi on computational modeling of SP.
Funds to purchase the Bruker 600 MHz NMR were provided by
the NIH (SIG 1-S10RR13878) and the NSF (EPSCOR- Montana).
Assays of SP repair were conducted at 30 °C under anaerobic
conditions; details are provided in SI. Under the HPLC conditions
utilized 5R-SP elutes at 19.3 min, 5S-SP elutes at 20.3 min, and
thymidine elutes at 14.4 min. As can be seen in Figure 2, time-
dependent formation of a peak with the retention time of thymidine
is observed when 5R-SP, but not when 5S-SP, is used as a substrate.
The identity of this emerging peak as thymidine was confirmed by
co-injection with authentic thymidine and by MS analysis of HPLC
fractions corresponding to the peak (SI). The synthetic SP as well
as the SP peaks in Figure 2 (m/z ) 485 (SP) and 507 (SP + Na)),
as well as the peak labeled T in Figure 2 (m/z ) 265 (T + Na)),
gave rise to the expected pattern upon MS analysis. MS analysis
of the small peaks eluting between 15 and 17 min show them to
result from inhomogenous mixture of small peptides, presumably
resulting from protein degradation during the sample workup. These
assays have been performed seven different times, on two different
protein samples, using two different buffers and two different
reducing agents (dithionite or 5-deazariboflavin), and in all cases
SPL repaired the 5R but not the 5S-SP.
Integration of the thymidine and SP peaks in the chromatograms
in Figure 2 have allowed us to quantify the rate of SP repair in this
system (Figure 2C) as ∼0.4 nmol/min/mg of SPL for the R isomer,
and 0 nmol/min/mg of SPL for the S isomer. These rates can be
compared to the rate of 0.33 µmol/min/mg when using B. subtilis
SPL and UV-irradiated plasmid DNA as a substrate.11 Little
additional SP turnover occurs after the 4 hour time point shown in
Figure 2C, likely due to enzyme instability under assay conditions,
and/or to enzyme inactivation. The lower rate of turnover for
synthetic dinucleoside SP relative to SP generated by UV irradiation
of plasmid DNA is not surprising, as the synthetic SP is not
Supporting Information Available: Synthetic methods and NMR
characterization of all synthetic SPs mentioned herein; NOESY and
ROESY of selected compounds; molecular modeling of SPs; mass spec
data on T and SP peaks from the HPLC-based assay. This material is
References
(1) Donnellan, J. E., Jr.; Setlow, R. B. Science 1965, 149, 308–310.
(2) Donnellan, J. E., Jr.; Stafford, R. S. Biophys. J. 1968, 8, 17–28.
(3) Varghese, A. J. Biochem. Biophys. Res. Commun. 1970, 38, 484–490.
(4) Setlow, P. Annu. ReV. Microbiol. 1995, 49, 29–54.
(5) Setlow, P. Trends Microbiol. 2007, 15, 172–180.
(6) Munakata, N.; Rupert, C. S. Mol. Gen. Genet. 1974, 130, 239–250.
(7) Fajardo-Cavazos, P.; Salazar, C.; Nicholson, W. L. J. Bacteriol. 1993, 175,
1735–1744.
(8) Rebeil, R.; Sun, Y.; Chooback, L.; Pedraza-Reyes, M.; Kinsland, C.; Begley,
T. P.; Nicholson, W. L. J. Bacteriol. 1998, 180, 4879–4885.
(9) Rebeil, R.; Nicholson, W. L. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9038–
9043.
(10) Cheek, J.; Broderick, J. B. J. Am. Chem. Soc. 2002, 124, 2860–2861.
(11) Buis, J. M.; Cheek, J.; Kalliri, E.; Broderick, J. B. J. Biol. Chem. 2006,
281, 25994–26003.
(12) Mehl, R. A.; Begley, T. P. Org. Lett. 1999, 1, 1065–1066.
(13) Kim, S. J.; Lester, C.; Begley, T. P. J. Org. Chem. 1995, 60, 6256–6257.
(14) Friedel, M. G.; Berteau, O.; Pieck, J. C.; Atta, M.; Ollagnier-de-Choudens,
S.; Fontecave, M.; Carell, T. Chem. Commun. 2006, 4, 445–447.
(15) Pieck, J. C.; Hennecke, U.; Pierik, A. J.; Friedel, M. G.; Carell, T. J. Biol.
Chem. 2006, 281, 36317–36326.
(16) Bu¨rckstu¨mmer, E.; Carell, T. Chem. Commun. 2008, 4037–4039.
(17) Mantel, C.; Chandor, A.; Gasparutto, D.; Douki, T.; Atta, M.; Fontecave,
M.; Bayle, P.-A.; Mouesca, J.-M.; Bardet, M. J. Am. Chem. Soc. 2008,
130, 16978–16984.
JA807375C
9
J. AM. CHEM. SOC. VOL. 131, NO. 7, 2009 2421